71
REFERÊNCIAS
1. Akasi, M, Koeffler, HP. Li Fraumeni Sipderone and Role of the p53 Tumor
Suppressor Gene in Câncer Susceptibility, Clinical Obstetrics and
Gynecology, (41):172-199,1998.
2. Alberts, B, Johnson, A, Lewis, J, Raff, M, Roberts, K, Walte,r P. Molecular
Biology of the Cell. 4. ed. New York: Garland Science; 2002.
3. Arends, MJ, Buckley, CH, Wells, MA. etiology, patengenesis, and pttology of
cervical neoplasia, J. Clin Pathol, (51):96-103,1998.
4. Berchuck, A, Kohler, MF, Marks, JR, Wislman, R, Boyd, J, Bast Jr., RC, The p53
tumor suppressor gene frequently es alteredis gynecologia cancers. AmericanJ.
Obstet Giprecol, (170):246-252, 1994.
5. Bornstein, J, Rahat, MA, Abramovici, 4 Etiology of Cewical Cancer; Current
concepts, Obstetrical and Gyccological Survey, (50):146-154, 1995.
6. Brasil, MS. Estimativa de incidência e mortalidade por câncer no Brasil.
Disponível em: <http//.inca.gov.br>. Acesso em: 13 out. 2008.
7. Chang, F, Syjanen, S, Syrjanen, K. Implicationsof the p53 Tumor Supressor
Gene in Clinical Oncology. Journal Clinical Oncology, (13):1009-1022, 1995.
8. Chiarugi, V, Ruggiero M. Role of the cancer “mater genes” p53, BCL 2 and C,
Myc on the apoptotic process, Tumori, (82):205-209, 1996.
9. Diamandw, EP. Clinical applications of the p53 tumor suppressor gene. Clinica
Chinica Acta, (237):79 -90, 1995.
10. Disaia, PJ, Creasman, WT. Clinical Gynecologic Oncology fifeth id., Mosby, 51-
106, 1997.
11. Franco, EL, Schlecht, NF, FS, Saslow, D. The Epidemiology of Cervical Cancer.
The Cancer Journal, 9(5): Sept./Oct. 2003.
12. Fisher et al., 1993.
13. Greenbla, MS, Benett, WP, Hollstein, M, Harris, CC. Mutation in the p53 Tumor
Supressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis. Cancer
Researd, (54):4855-4878, 1994.
14. Halse, HW. Tratado de Ginecologia, Segunda ed., Rocc (2):1807-1854, 1995.
15. Harris, CC. p-53 Tumor Supresor Gene: At The Crossroacs of Molecular
Carcinogenesis, Molecular Epidemiology and Cancer Risk Assessment.
Envieromnental Health Persp, (104):435-439, 1996.